Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit

September 23, 2019 at 10:00 am

Emerging Infectious Diseases October 2019 V.25 N.10

We decreased antimicrobial drug consumption in an intensive care unit in Lebanon by changing to colistin monotherapy for extensively drug-resistant Acinetobacter baumanii infections. We saw a 78% decrease of A. baumanii in sputum and near-elimination of blaoxa-23-carrying sequence type 2 clone over the 1-year study. Non–A. baumanii multidrug-resistant infections remained stable.

FULL TEXT

https://wwwnc.cdc.gov/eid/article/25/10/18-1626_article?deliveryName=DM9244

PDF (CLIC en DOWNLOADS / ARTICLE)

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, BIOFILM - BIOPELICULAS, Biología Molecular, BIOMARCADORES, Desinfection and Sterilization, Epidemiología, Health Care-Associated Infections, Infecciones nosocomiales, Metodos diagnosticos, Prevencion y Control de Infecciones, REPORTS, Resistencia bacteriana, Sepsis, Update.

Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China A New Perspective on HIV Diagnostics: Reinterpretation in the Age of Early Treatment


Calendar

September 2019
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Most Recent Posts


%d bloggers like this: